3/19
Perelman School of Medicine
The best way to prevent HIV is often out of reach for women and marginalized people
LDI fellows are working with local communities to increase PrEP use through improving the message about the drug, reducing stigma, and normalizing the conversation about HIV infection.
This season’s flu and COVID-19 vaccines
Judith A. O’Donnell of the Perelman School of Medicine answers common questions about this year’s flu shot and the new COVID-19 vaccines.
The immune health future, today
Breaking the code of the immune system could provide a new fundamental way of understanding, treating, and preventing every type of disease. Penn Medicine is investing in key discoveries about immunity and immune system function, and building infrastructure, to make that bold idea a reality.
Inflammatory bowel disease linked to atopic dermatitis
Findings from researchers from Penn Medicine link an increased risk of inflammatory bowel disease with the presence of atopic dermatitis, which can lead to new treatments for both.
An unsolved mystery: Why are we sleepy when sick?
David Raizen, a professor of neurology, alongside PURM student Hina Sako, spent the summer moving forward research examining how sickness affects sleep.
Deans of health schools discuss climate change in their fields
Deans and leaders from the schools of Medicine, Veterinary Medicine, Dental Medicine, Nursing, and Social Policy & Practice discussed climate and health at a Climate Week event.
The brain-blood barrier’s role in governing ant behavior
New research from Penn Medicine uncovers a link between a single enzyme and complex social behaviors in ants.
Removing the barrier surrounding solid tumors clears path for T cells
Penn researchers uncover a new way to target solid tumors. Using CAR T cells to remove cancer-associated fibroblasts surrounding pancreatic tumors allows T cells to infiltrate and attack the tumor cells.
Can the COVID playbook help end malaria?
In a Perry World House conversation, Matthew Laurens, Martina Mchenga, and Drew Weissman discussed how lessons from a global pandemic could help in the fight to eradicate malaria.
Penn Medicine’s Carl June to receive 2024 Breakthrough Prize in Life Sciences
The Richard W. Vague Professor in Immunotherapy in the Perelman School of Medicine is honored for pioneering the development of CAR T cell therapy, which programs patients’ own immune cells to fight their cancer.
In the News
Sugar-coated gold nanoparticles could replace some antibiotics
According to a Penn Medicine study, a new therapy involving laser light and sugar-coated gold nanoparticles can reduce tooth decay and infected wounds without needing antibiotics.
FULL STORY →
A new strategy to attack aggressive brain cancer shrank tumors in two early tests
A clinical trial led by Stephen Bagley of the Perelman School of Medicine suggests that targeting two associated proteins with CAR T cell therapy could be a viable strategy for shrinking brain tumors.
FULL STORY →
Alzheimer’s may be caused by a build-up of fat in brain cells
A study by Michael Haney of the Perelman School of Medicine suggests that the root cause of Alzheimer’s is a build-up of fat droplets in brain cells.
FULL STORY →
Philadelphia hospital program adds psychologists to bridge mental health services for trauma survivors
A new psychology team at the Penn Trauma Violence Recovery Program has provided about 46 survivors with short- and long- term therapy, featuring remarks from Elinore Kaufman and Lily Brown of the Perelman School of Medicine.
FULL STORY →
Social factors may ‘disproportionately’ affect transplant process
A 2023 study led by researchers at Penn found that 44% of patients evaluated for liver transplants were not placed on organ wait lists, with nearly 17% rejected because of psychosocial or financial reasons. Marina Serper and Tamara Cozzi of Penn Medicine discuss the evaluation process for transplants.
FULL STORY →